Abbott Next Generation Drug Eluting Stent 48mm Study

Completed · Not applicable

Conditions studied: Coronary Artery Disease

In brief

The purpose of this SPIRIT 48 study is to evaluate the safety and effectiveness of the ABT NG DES 48 in improving coronary artery luminal diameter in subjects with coronary artery disease (CAD) due to de novo native coronary artery long lesions.

Key facts

Study ID
NCT04282148
Run by
Abbott Medical Devices
People needed
107
Starts
2020-06-17
Expected to finish
2023-09-17
Last updated by the study team
2025-01-08

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.